GGS
MRK icon

Galvin Gaustad & Stein’s Merck MRK Stock Holding History

Galvin Gaustad & Stein’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Buy
5,221
+35
+0.7% +$4.1K 0.05% 160
2026
Q1 		$624K Buy
5,186
+210
+4% +$24.2K 0.05% 159
2025
Q4 		$524K Buy
4,976
+1,414
+40% +$133K 0.04% 163
2025
Q3 		$299K Buy
3,562
+167
+5% +$13.8K 0.02% 169
2025
Q2 		$269K Sell
3,395
-1,799
-35% -$143K 0.02% 169
2025
Q1 		$466K Buy
5,194
+986
+23% +$92.1K 0.04% 133
2024
Q4 		$419K Buy
4,208
+189
+5% +$19.5K 0.04% 143
2024
Q3 		$456K Sell
4,019
-414
-9% -$49.2K 0.04% 137
2024
Q2 		$549K Sell
4,433
-34
-0.8% -$4.38K 0.05% 121
2024
Q1 		$589K Sell
4,467
-144
-3% -$17.7K 0.05% 114
2023
Q4 		$503K Sell
4,611
-154
-3% -$16K 0.05% 122
2023
Q3 		$491K Sell
4,765
-201
-4% -$21.7K 0.05% 121
2023
Q2 		$573K Sell
4,966
-109
-2% -$12.4K 0.06% 114
2023
Q1 		$540K Buy
5,075
+128
+3% +$13.8K 0.05% 110
2022
Q4 		$549K Sell
4,947
-105
-2% -$10.7K 0.06% 111
2022
Q3 		$435K Buy
5,052
+30
+0.6% +$2.68K 0.05% 120
2022
Q2 		$458K Sell
5,022
-189
-4% -$16.8K 0.05% 119
2022
Q1 		$428K Sell
5,211
-1,011
-16% -$79.7K 0.04% 129
2021
Q4 		$477K Sell
6,222
-619
-9% -$49.3K 0.04% 127
2021
Q3 		$514K Sell
6,841
-184,884
-96% -$14.1M 0.05% 126
2021
Q2 		$14.9M Sell
191,725
-398
-0.2% -$29.6K 1.42% 27
2021
Q1 		$14.1M Buy
192,123
+28,381
+17% +$2.09M 1.42% 28
2020
Q4 		$12.8M Buy
+163,742
New +$12.5M 1.34% 32

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Galvin Gaustad & Stein's MRK Position: Q2 2026 in Review

Galvin Gaustad & Stein increased its Merck (MRK) stake by 0.67% in Q2 2026, buying an estimated $4.1K and bringing the position to 5,221 shares worth $671K. The position accounts for 0.05% of the portfolio, ranked #160.

Galvin Gaustad & Stein first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $14.9M in Q2 2021. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Galvin Gaustad & Stein held 5,221 shares of Merck worth $671K as of Q2 2026.
  • Galvin Gaustad & Stein bought 35 Merck shares in Q2 2026, an estimated $4.1K.
  • Merck made up 0.05% of Galvin Gaustad & Stein's portfolio in Q2 2026, its #160 holding.
  • Galvin Gaustad & Stein first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Galvin Gaustad & Stein's Merck position peaked at $14.9M in Q2 2021.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q2 2026, filed 29 Jul 2026.